Thank you, Mr. Chair.
I am honoured to hear your testimony. You are experts, leaders in the field, and you have worked on these issues for many years. That said, I have the impression that this is work in progress that we'll never see the end of. We must learn to cope with this phenomenon and establish a plan of attack. This is what we are trying to do together. The testimony we've heard so far has given me the impression that the work was done in a vacuum. It's very difficult in terms of communications and interrelations, whether it's here, at home or elsewhere. Indeed, I have the impression that it is a global scourge.
What are the global consequences of not addressing antibiotic resistance or not addressing it adequately?
I would say, in my own words, that there are outbreaks worldwide, possibly in the third world, where antibiotic resistance is triggered.
Canada is one of the developed countries that has strategies in this regard. But I would like to know what it costs us not to help developing countries with insufficient strategies and action plans they can't implement effectively. As you told us earlier, people don't take all of the medication they have been prescribed, or they take too much because they want to find a quick fix to their problems, which could be solved otherwise.
My question is fairly broad, but I would like Mr. Wright and Mr. Evans, in particular, to respond. If the other witnesses want to add something, I would like them to feel welcome to do so.